Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Latvia

Q2 Pharmaceutical Sales Contraction Signals Further Troubles For 2009

September 2009 | Industry Trend Analysis

Pharmaceuticals sales in Latvia showed negative year-on-year (y-o-y) growth during the second quarter of 2008, concurrent with the release of abysmal GDP data and rocketing unemployment. Wholesale values were down 1.4%, following a y-o-y expansion of 3.8% in Q109. Combined results see H109 sales up just 1.1% y-o-y, a growth figure BMI believes may see further erosion by year end, with 2009 growth projected at just 0.75% in local currency, or -20.35% in US dollar

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries